These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21125190)

  • 41. Is oxidized low-density lipoprotein the connection between atherosclerosis, cardiovascular risk and nephrolithiasis?
    de Freitas ACP; Torres LC; Duarte MDCMB; da Matta MC; Casarini DE; Schor N
    Urolithiasis; 2019 Aug; 47(4):347-356. PubMed ID: 30302491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serological correlations with nephritis in systemic lupus erythematosus.
    Reichlin M
    Clin Immunol; 2005 Oct; 117(1):12-4. PubMed ID: 16006192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.
    Peters MJ; van Halm VP; Nurmohamed MT; Damoiseaux J; Tervaert JW; Twisk JW; Dijkmans BA; Voskuyl AE
    J Rheumatol; 2008 Aug; 35(8):1495-9. PubMed ID: 18597411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
    Karpe F; Tornvall P; Olivecrona T; Steiner G; Carlson LA; Hamsten A
    Atherosclerosis; 1993 Jan; 98(1):33-49. PubMed ID: 8457249
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein.
    Romero FI; Amengual O; Atsumi T; Khamashta MA; Tinahones FJ; Hughes GR
    Br J Rheumatol; 1998 Aug; 37(8):883-8. PubMed ID: 9734680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis.
    Pereira I; Laurindo I; Burlingame R; Anjos L; Viana V; Leon E; Vendramini M; Borba E
    Joint Bone Spine; 2008 Jul; 75(4):416-21. PubMed ID: 18457983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibodies binding to anionic phospholipids but not to oxidized low-density lipoprotein are associated with thrombosis in patients with systemic lupus erythematosus.
    Aho K; Vaarala O; Tenkanen L; Julkunen H; Jouhikainen T; Alfthan G; Palosuo T
    Clin Exp Rheumatol; 1996; 14(5):499-506. PubMed ID: 8913651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Pitavastatin on Lipoprotein Subfractions and Oxidized Low-density Lipoprotein in Patients with Atherosclerosis.
    Xu RX; Zhang Y; Zhang Y; Wu YR; Li XL; Guo YL; Liu G; Dong Q; Li JJ
    Curr Med Sci; 2020 Oct; 40(5):879-884. PubMed ID: 33123903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
    Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
    J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibodies against various forms of mildly oxidized low-density lipoprotein are not associated with carotid intima-media thickness in patients with primary hyperlipidemia.
    Tsouli SG; Kiortsis DN; Xydis V; Argyropoulou MI; Elisaf M; Tselepis AD
    Angiology; 2006; 57(5):615-22. PubMed ID: 17067985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    McMahon M; Grossman J; FitzGerald J; Dahlin-Lee E; Wallace DJ; Thong BY; Badsha H; Kalunian K; Charles C; Navab M; Fogelman AM; Hahn BH
    Arthritis Rheum; 2006 Aug; 54(8):2541-9. PubMed ID: 16868975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients.
    Oi K; Hirano T; Sakai S; Kawaguchi Y; Hosoya T
    Kidney Int Suppl; 1999 Jul; 71():S227-8. PubMed ID: 10412783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
    Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of biological markers of activity of systemic lupus erythematosus with levels of anti-oxidized low-density lipoprotein antibodies.
    Gómez-Zumaquero JM; Tinahones FJ; De Ramón E; Camps M; Garrido L; Soriguer FJ
    Rheumatology (Oxford); 2004 Apr; 43(4):510-3. PubMed ID: 14872100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
    Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
    J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disease Activity, Oxidized-LDL Fraction and Anti-Oxidized LDL Antibodies Influence Cardiovascular Risk in Rheumatoid Arthritis.
    Nowak B; Madej M; Łuczak A; Małecki R; Wiland P
    Adv Clin Exp Med; 2016; 25(1):43-50. PubMed ID: 26935497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxidation of LDL and its clinical implication.
    Matsuura E; Hughes GR; Khamashta MA
    Autoimmun Rev; 2008 Jul; 7(7):558-66. PubMed ID: 18625445
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.
    Lopez LR; Hurley BL; Simpson DF; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():97-103. PubMed ID: 16126948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.